Integration of Liquid Biopsy for Optimal Management of Non-small Cell Lung Cancer
Molecular profiling of tumors from patients plays a crucial role in precision oncology. While tumor tissue-based genomic testing remains the gold standard in clinical management of patients with non-small cell lung cancer, advances in genomic technologies, the analysis of various bodily fluids, main...
Saved in:
Main Authors: | Yuko Oya, Ichidai Tanaka, Ross A. Soo |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2025-07-01
|
Series: | Tuberculosis and Respiratory Diseases |
Subjects: | |
Online Access: | http://e-trd.org/upload/pdf/trd-2024-0146.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating tumor DNA detection (liquid biopsy): prospects in oncology
by: N. V. Zhukov, et al.
Published: (2015-01-01) -
The advances of DNA methylation in the liquid biopsy for the detection of lung cancer
by: Yuxuan Chen, et al.
Published: (2025-07-01) -
Liquid Biopsy: Current Status and Future Perspective in Gastric Cancer and Helicobacter Infection
by: Eun A Kang, et al.
Published: (2018-09-01) -
Integrative analysis of circulating tumor cells (CTCs) and exosomes from small‐cell lung cancer (SCLC) patients: a comprehensive approach
by: Dimitrios Papakonstantinou, et al.
Published: (2025-07-01) -
Liquid Biopsy: Current advancements in clinical practice for bladder cancer
by: Felice Crocetto, et al.
Published: (2025-09-01)